Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as read-only, idempotent, open-world, and non-destructive, so the bar is lower; the description still adds substantial behavior beyond that: cascading through multiple lookup endpoints, graceful degradation if GLEIF or OpenFIGI is unavailable, returning figi_candidates on ambiguity rather than asserting, and explicitly reporting unresolved identifiers. No annotation contradiction exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is appropriately front-loaded with purpose and 'Use FIRST,' but the SUPPORTED TYPES section is dense, uses long nested parentheticals, and repeats the name-to-ID idea. The content is valuable, but readability would improve by separating the two entity types and trimming redundant rationale.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return behavior, and it does so well: CIK, ticker, company_name, LEI with ownership, FIGI, RxCUI/ingredient/brand/citation, figi_candidates for ambiguity, and unresolved identifiers. Graceful degradation and source labelling are also covered, leaving no major gap for selection or invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds critical meaning beyond the schema: it documents ISIN as an accepted company input, instructs callers to pass the bare entity name rather than the full noun phrase, and explains why trailing security-class words cause FIGI lookup failure. This is exactly the kind of semantic guidance a schema alone rarely provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a clear verb and resource: resolve user-spoken names to canonical/official identifiers other tools require. It opens with concrete query examples and explicitly says 'Use FIRST whenever you have a name but need an ID,' which distinguishes it from sibling lookup/profile tools. It also enumerates supported types, making its scope immediately recognizable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID,' and explains when 'company' vs 'drug' applies, including acceptable input forms. It does not name specific sibling tools to avoid in favor of this one, so exclusions are implied rather than stated.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all answer natural-language data questions. The six Polymarket/prediction-market tools also blur together, and ai_visibility_check versus scan_competitor_ai_presence are near-duplicates.

Naming Consistency4/5

Snake_case is used consistently, and most tools follow a verb-first or domain-prefixed pattern (ask_pipeworx, compare_entities, subscribe, polymarket_*). Minor deviations like entity_profile, resource_data, and ai_visibility_check are noun-first, but nothing is chaotic or mixed-cased.

Tool Count2/5

33 tools is excessive for a server named 'Data Gov In' whose actual domain-specific surface is only resource_data and resource_meta. The rest are generic Pipeworx, prediction-market, memory, and utility tools that do not belong to the apparent India open-data scope.

Completeness1/5

For a data.gov.in server, the surface is severely incomplete: there is no way to search or list datasets/resources, only fetch metadata and data for a known resourceId. The overwhelming majority of tools serve unrelated domains, so an agent using this server for Indian government data will hit dead ends immediately.